USANA Health Sciences (NYSE:USNA) Releases Earnings Results, Beats Expectations By $0.20 EPS

USANA Health Sciences (NYSE:USNA - Get Free Report) released its earnings results on Tuesday. The company reported $0.74 EPS for the quarter, topping analysts' consensus estimates of $0.54 by $0.20, Zacks reports. USANA Health Sciences had a net margin of 3.98% and a return on equity of 8.94%. USANA Health Sciences updated its FY 2025 guidance to 2.350-3.000 EPS.

USANA Health Sciences Stock Up 4.7%

USNA stock traded up $1.42 during trading on Tuesday, hitting $31.71. 153,108 shares of the company's stock traded hands, compared to its average volume of 142,042. USANA Health Sciences has a 52 week low of $23.10 and a 52 week high of $46.44. The stock has a fifty day moving average price of $30.64 and a two-hundred day moving average price of $30.12. The stock has a market capitalization of $590.44 million, a price-to-earnings ratio of 17.42, a price-to-earnings-growth ratio of 0.97 and a beta of 0.64.

Insider Activity

In other USANA Health Sciences news, CFO G Doug Iiekking sold 4,548 shares of the company's stock in a transaction dated Friday, May 9th. The shares were sold at an average price of $29.61, for a total transaction of $134,666.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Walter Noot sold 6,291 shares of the stock in a transaction that occurred on Tuesday, May 27th. The stock was sold at an average price of $30.29, for a total value of $190,554.39. The disclosure for this sale can be found here. Insiders have sold 12,013 shares of company stock valued at $360,149 in the last 90 days. Insiders own 0.63% of the company's stock.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in USANA Health Sciences stock. AQR Capital Management LLC raised its position in USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 82.8% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 21,845 shares of the company's stock after acquiring an additional 9,894 shares during the period. AQR Capital Management LLC owned about 0.12% of USANA Health Sciences worth $589,000 as of its most recent filing with the SEC. Hedge funds and other institutional investors own 54.25% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded shares of USANA Health Sciences from a "hold" rating to a "buy" rating in a research note on Thursday, May 22nd.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.